 Antibodies, Viral
"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 0 | 4 | 4 | | 1998 | 2 | 3 | 5 | | 1999 | 2 | 3 | 5 | | 2000 | 1 | 0 | 1 | | 2001 | 2 | 4 | 6 | | 2002 | 0 | 2 | 2 | | 2003 | 2 | 6 | 8 | | 2004 | 1 | 6 | 7 | | 2005 | 2 | 4 | 6 | | 2006 | 3 | 5 | 8 | | 2007 | 5 | 6 | 11 | | 2008 | 2 | 7 | 9 | | 2009 | 2 | 11 | 13 | | 2010 | 2 | 5 | 7 | | 2011 | 6 | 3 | 9 | | 2012 | 6 | 4 | 10 | | 2013 | 4 | 5 | 9 | | 2014 | 4 | 7 | 11 | | 2015 | 9 | 6 | 15 | | 2016 | 2 | 7 | 9 | | 2017 | 5 | 15 | 20 | | 2018 | 6 | 13 | 19 | | 2019 | 9 | 10 | 19 | | 2020 | 13 | 17 | 30 | | 2021 | 24 | 29 | 53 | | 2022 | 3 | 37 | 40 | | 2023 | 0 | 17 | 17 | | 2024 | 10 | 16 | 26 | | 2025 | 15 | 15 | 30 | | 2026 | 6 | 3 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Acciani M, Zyla D, Niemeyer G, Harkins S, Parekh D, Pawlack E, Lacarbonara D, Kansara D, Ackerman ME, Niewiesk S, Porotto M, Hastie KM, Saphire EO. Human neutralizing antibodies targeting the measles virus hemagglutinin and fusion surface proteins. Cell Host Microbe. 2026 Jun 10; 34(6):1067-1081.e12.
-
Campbell AJ, Shephard M, Paulos AP, Pauly MD, Vu MN, Stenkamp-Strahm C, Bushfield K, Hunter-Binns B, Sablon O, Bendall EE, Fitzimmons WJ, Brizuela K, Quirk GE, Kumar N, McCluskey B, Shetty N, Marr LC, Guthmiller JJ, Santos JJS, Hensley SE, Marshall ES, Abernathy K, Lauring AS, Melody BT, Wolfe MK, Lombard J, Lakdawala SS. Surveillance on California dairy farms reveals multiple possible sources of H5N1 influenza virus transmission. PLoS Biol. 2026 May; 24(5):e3003761.
-
Crofts KF, Holbrook BC, Page CL, Hendrix CJ, Caudell D, Gillespie RA, D'Agostino RB, Moin SM, Sangesland M, Ornelles DA, Kanekiyo M, Alexander-Miller MA. A dual-adjuvanted HA stem nanoparticle vaccine elicits a multifunctional antibody response that is associated with protection in newborn monkeys. Cell Rep Med. 2026 May 19; 7(5):102746.
-
Zyla DS, Della Marca R, Lacarbonara D, Niemeyer G, Zipursky G, Di Clemente L, Verbruggen MHL, van Dijk LLA, Ceh OM, Jonathan-Trakht G, Kalantarov G, Acciani M, Laterza G, Vyshenska D, Leedale C, Pawlack E, Hastie KM, Horvat B, de Swart RL, de Vries RD, Greninger AL, Niewiesk S, Ollmann Saphire E, Porotto M. Structural and mechanistic basis for antibody neutralization of the measles fusion protein. Nat Commun. 2026 Apr 06; 17(1).
-
Silva MVM, Ximenes RAA, Filho DBM, Martelli CMT, de Araújo TVB, Brickley E, Fontes JMSSA, Fulco GRN, Sá ACCL, Cordeiro MT, Castanha PMDS, Dos Santos Oliveira PA, Montarroyos UR. Kinetics of neutralizing and binding antibody responses following Zika virus infection during pregnancy: A nested analysis of participants from the microcephaly epidemic research group (MERG) and Zika in infants and pregnancy (ZIP) cohorts. Virus Res. 2026 Jun; 368:199725.
-
Bauer RA, Yang Z, Petriello M, Zhang S, Stapleton HM, Adgate JL, Carignan CC. Associations of serum PFAS with COVID-19 antibody levels among fully vaccinated adults. Environ Res. 2026 Jun 01; 298:124154.
-
Roubinian NH, Plimier C, Spencer BR, Bravo M, Custer B, D'Alessandro A, Kleinman S, Norris PJ, Busch MP. Transfusion requirements in recipients of plasma units from blood donors with recent SARS-CoV-2 infection. Transfusion. 2026 Apr; 66(4):651-655.
-
Kpetigo AD, Alexandre M, Camara A, Beavogui A, Doumbia S, Kieh M, Leigh B, Sow S, Wittkop L, Soutthiphong AA, Berry IM, Fleck S, Akoo P, Hamze B, Watson-Jones D, Kuhn JH, Greenwood B, Richert L, Yazdanpanah Y, Lévy Y, Thiébaut R, Prague M, Lhomme E. Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial. PLoS Negl Trop Dis. 2026 Jan; 20(1):e0013950.
-
Ustianowski A, Levin MJ, De Wit S, Launay O, Veekmans B, Rampling T, Sullivan JG, Vishnepolsky M, Wijewardane P, Fawadleh Y, Zhang H, Li M, Wickramarachchi D, Sharbaugh A, Beavon R, Thissen J, Hirao L, Dzutseva V, Seegobin S, Streicher K, Kiazand A, Esser MT, Chang LJ, Perez JL, Cohen TS. Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-study. Clin Drug Investig. 2026 Feb; 46(2):207-219.
-
Toews E, Shaikh S, Akter S, Zhang C, Selemon A, Arora RK, Bobrovitz N, Jaenisch T, Ware H, Whelan MG. Serological and viral prevalence of Oropouche virus (OROV): A systematic review and meta-analysis from 2000-2024 including human, animal, and vector surveillance studies. PLoS Negl Trop Dis. 2025 Dec; 19(12):e0013340.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|